on day 4-5, and a third on day 10-14. A total number of 1000 patients with SARS-COV-2 infection are included in the CRIT-COV study. The distribution of the severity should include 33% (approx. 330) outpatients [...] the website: www.vicorek-nds.de Funded by the Federal Institute for Drugs and Medical Devices CRIT-COV-U 01 / Prospective validation of a urine test for the early and accurate prognosis of critical com [...] Bettina Rohde Department / Institute: HCTC-KKS - Coordinating Center for Clinical Studies, MHH The CRIT-COV study is a prospective, single-arm, multi-center, international, observational study. Three urine samples
Medical School (MHH). During their visit, the West African experts have focused their attention on SARS-Cov-2/COVID 19 research and treatment at MHH. Professor Frimpong-Boateng was asked by the Ghanaian President [...] Professor Haverich - and the heart surgeon has been able to win over all the leading figures in SARS-Cov-2/COVID 19 research and treatment for a professional exchange, in addition to the MHH Executive Board
PY WITH T CELLS A Phase I/ Randomized Phase II Trial To Analyse Safety And Efficacy Of Human SARS-COV-2-Specific T Lymphocyte Transfer In Patients With COVID-19 In Need Of Treatment Or At Risk Of Severe [...] gov: NCT04762186 EudraCT number: 2021-000417-16 Publications : Long-Lasting Immunity Against SARS-Cov-2: Dream or Reality? Gussarow D, Bonifacius A, Cossmann A, Stankov MV, Mausberg P, Tischer-Zimmermann
of strongly neutralizing antibodies against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS COV-2) infections, which includes the structural modeling of antibody-antigen complexes, the modeling of
recovered). Due to many inquiries, we would like to assure you that there is no increased risk of SARS-Cov-2 infection for donors due to the high and currently even stricter hygiene standards in our blood donation
Telemedicine-supported rehabilitation after COVID-19 TelPoCO Infections with the SARS-Cov-2 virus have been occurring in Germany since the beginning of 2020. One secondary disease is post-COVID-19 syndrome
are interested, please send an email to Braesen.Jan @ mh-hannover.de Kidney CNN on Jones-HE | SARS-COV-2-FISH (RNA) Automatic structure recognition kidney | kidney cancer: T-cell detection Antibody-mediated
Funded by the pharmaceutical industry Vakzine Projekt Management GmbH VPM1002-DE-3.07CoV / Prevention of SARS-CoV2-infection by modulating the immune system Project leader: Prof. Dr. med. Christoph Schindler [...] Hannover together with up to 13 additional centres in Germany. FGK Clinical Research GmbH VPM1002-DE-3.06CoV / SARS-CoV2-prevention by immunmodulation in health care workers Project leader: Prof. Dr. med. Christoph
athletes and their prospective development, as well as the attainment of sufficient immunity against SARS-Cov-2. Further information... Digitalization for sustainable mobility - DiNaMo " Digitalization for Sustainable [...] therapy and their combination in patients with post-COVID-19 syndrome (TelPoCo) Infections with the SARS-Cov-2 virus have been occurring in Germany since the beginning of 2020. One secondary disease is post-COVID-19
Network Lower Saxony | UMG COFONI Projects at LEBAO Project: Role of TMPRSS2 proteolysis in SARS - CoV-2 spread in cells of the respiratory tract and in vivo Several highly effective vaccines have been